Hans Biomed expands BOUNS breast implant supply to South Korean hospitals
AI Summary- Hans Biomed expanded BOUNS supply to four South Korean tertiary general hospitals.
- The company plans to add 25 more tertiary general hospitals by year-end.
- BOUNS launched in South Korea in April as Bellagel's successor.